We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Novotech Health Holdings, the largest biotech specialist contract research organization (CRO) in Asia, today announced the appointment of Zidong Zhang as Chief Financial Officer (CFO) effective 4 January 2021.